Heart Valve, Spine Markets To Drive Device Growth After DES – CMS Report
This article was originally published in The Gray Sheet
Executive Summary
Percutaneous heart valve repair and replacement likely will drive the next wave of medical device industry expansion as cardiac resynchronization therapy (CRT) and drug-eluting stent innovations plateau, a CMS report speculates
You may also be interested in...
FDA Review Criteria Are Insufficient To Prompt CMS Coverage – Feigal, Tunis
Proposals allowing FDA's approval criteria to play a greater role in Medicare coverage determinations should account for the fact that many devices are cleared via 510(k) and not reviewed for clinical effectiveness, CDRH Director David Feigal asserted Oct. 11
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.